Recap: Mednax Q3 Earnings

Shares of Mednax MD rose 5.3% in pre-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share fell 59.34% year over year to $0.37, which missed the estimate of $0.40.

Revenue of $460,635,000 up by 1.26% year over year, which missed the estimate of $535,390,000.

Guidance

Mednax hasn't issued any earnings guidance for the time being.

Mednax hasn't issued any revenue guidance for the time being.

Conference Call Details

Date: Nov 06, 2020

Time: 09:00 AM

ET Webcast URL: https://edge.media-server.com/mmc/p/3c4h3xi9

Technicals

Company's 52-week high was at $28.66

Company's 52-week low was at $7.37

Price action over last quarter: down 25.93%

Company Description

Mednax provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment, which is physician services. Mednax generates roughly half of its revenue from the women's and children's services provided, and also roughly half of the company's total revenue is earned in the United States.